Innovative assessment of inpatient and pulmonary drug costs for children with cystic fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Innovative assessment of inpatient and pulmonary drug costs for children with cystic fibrosis

Published:2016-10-14 Issue:12 Volume:51 Page:1295-1303
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol.

Author:

Levy Joseph F.¹,Rosenberg Marjorie A.²,Farrell Philip M.¹³

Affiliation:

1. Department of Population Health Sciences; School of Medicine and Public Health; University of Wisconsin-Madison; Madison Wisconsin

2. Department of Risk and Insurance; University of Wisconsin School of Business; Madison Wisconsin

3. Departments of Pediatrics; University of Wisconsin School of Medicine and Public Health; Madison Wisconsin

Funder

National Institutes of Health

Clinical and Translational Science Award, National Center for Research Resources

National Institute of Mental Health Training

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ppul.23554/fullpdf

Reference40 articles.

1. Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program;Lee;J Pediatr,2003

2. A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis;Wells;Pediatrics,2012

3. Costs and health-related quality of life of patients with cystic fibrosis and their carers in France;Chevreul;J Cyst Fibros,2015

4. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom;Angelis;BMC Health Serv Res,2015

5. Understanding the costs of care for cystic fibrosis: an analysis by age and health state;van Gool;Value Health,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Underreporting of patient-reported outcomes in cystic fibrosis randomized controlled trials using CONSORT-PRO and RoB 2.0;Respiratory Medicine and Research;2023-06

2. Prenatal Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Promising Way to Change the Impact of Cystic Fibrosis;Fetal Diagnosis and Therapy;2023

3. A case report of CFTR modulator administration via carrier mother to treat meconium ileus in a F508del homozygous fetus;Journal of Cystic Fibrosis;2022-07

4. Hospital costs of Canadian cystic fibrosis patients;Canadian Journal of Respiratory, Critical Care, and Sleep Medicine;2021-03-23

5. Extracellular DNA in sputum is associated with pulmonary function and hospitalization in patients with cystic fibrosis;Respiratory Medicine;2020-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3